MRI Study of High Definition Transcranial Electrical Stimulation in Chronic Tinnitus (MRI HDtES-T)

(MRI HDtES-T Trial)

Overseen By Amber Leaver

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: Northwestern University

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Approved in 2 Jurisdictions This treatment is already approved in other countries

Compensation: Varies

Number of Visits: Unknown

20 Participants Needed

Trial Summary

What is the purpose of this trial?

This trial is testing a gentle brain stimulation technique called HDtES on adults who have chronic ringing in their ears. The treatment uses small electrodes to send a mild electrical current through the scalp, aiming to change brain activity and connections. Researchers will measure changes in brain function and tinnitus symptoms over time. High-definition transcranial direct current stimulation (HD-tDCS) has been explored in previous studies for its potential to modulate brain activity and improve auditory processing in tinnitus patients.

Eligibility Criteria

Inclusion Criteria

You have the capacity to give informed consent.

You have discussed tinnitus symptoms with clinician to confirm low/no likelihood of physical or neurological origin of tinnitus symptoms (e.g., acoustic neuroma, Meniere's Disease, etc.), confirmed by patient self-report.

Ages between 18 and 75

Treatment Details

Interventions

• Transcranial Direct Current Stimulation

Participant Groups

Group I: Active Experimental Treatment 1 Intervention

Group II: Sham Placebo Group 1 Intervention

Transcranial Direct Current Stimulation is already approved in United States, European Union for the following indications:

Approved in United States as Transcranial Direct Current Stimulation for:

• Chronic pain management
• Depression
• Anxiety

Approved in European Union as Transcranial Direct Current Stimulation for:

• Chronic pain management
• Neurological rehabilitation

Who Is Running the Clinical Trial?

Northwestern University

Lead Sponsor

Trials

1,674

Recruited

989,000+